Design, Synthesis and Biological Evaluation of Novel MDH Inhibitors Targeting Tumor Microenvironment
Authors:
- Sreenivasulu GodesiSGSreenivasulu Godesi
- Jeong-Ran HanJHJeong-Ran Han
- Jang-Keun KimJKJang-Keun Kim
- Dong-Ik KwakDKDong-Ik Kwak
- Joohan LeeJLJoohan Lee
- Hossam NadaHNHossam Nada
- Minkyoung KimMKMinkyoung Kim
- Hyun-A YangHYHyun-A Yang
- Joo-Young ImJIJoo-Young Im
- Hyun Seung BanHBHyun Seung Ban
- Chang Hoon LeeCLChang Hoon Lee
- Yongseok ChoiYCYongseok Choi
Open Access
- 2 May 2023
- journal article
- research article
- Published by MDPI AG in Pharmaceuticals
- Vol. 16 (5) , 683
Abstract
MDH1 and MDH2 enzymes play an important role in the survival of lung cancer. In this study, a novel series of dual MDH1/2 inhibitors for lung cancer was rationally designed and synthesized, and their SAR was carefully investigated. Among the tested compounds, compound 50 containing a piperidine ring displayed an improved growth inhibition of A549 and H460 lung cancer cell lines compared with LW1497. Compound 50 reduced the total ATP content in A549 cells in a dose-dependent manner; it also significantly suppressed the accumulation of hypoxia-inducible factor 1-alpha (HIF-1α) and the expression of HIF-1α target genes such as GLUT1 and pyruvate dehydrogenase kinase 1 (PDK1) in a dose-dependent manner. Furthermore, compound 50 inhibited HIF-1α-regulated CD73 expression under hypoxia in A549 lung cancer cells. Collectively, these results indicate that compound 50 may pave the way for the development of next-generation dual MDH1/2 inhibitors to target lung cancer.Keywords
Funding Information
- National Research Foundation of Korea (NRF) grants funded by the Korean government (MSIT) (2018R1A5A2023127, 2019M3E505066636, 2021R1A2C1013746, 2023R1A2C3004599, KGM5192322)
- BK21 FOUR program and KRIBB Research Initiative Program (2018R1A5A2023127, 2019M3E505066636, 2021R1A2C1013746, 2023R1A2C3004599, KGM5192322)
This publication has 34 references indexed in Scilit:
- Nrf2 Redirects Glucose and Glutamine into Anabolic Pathways in Metabolic ReprogrammingCancer Cell, 2012
- Oncogenic Kras Maintains Pancreatic Tumors through Regulation of Anabolic Glucose MetabolismCell, 2012
- Hallmarks of Cancer: The Next GenerationCell, 2011
- Targeting lactate-fueled respiration selectively kills hypoxic tumor cells in miceJournal of Clinical Investigation, 2008
- HIF-1-mediated expression of pyruvate dehydrogenase kinase: A metabolic switch required for cellular adaptation to hypoxiaCell Metabolism, 2006
- HIF-1 mediates adaptation to hypoxia by actively downregulating mitochondrial oxygen consumptionCell Metabolism, 2006
- Estrogen receptor ligands. Part 3: The SAR of dihydrobenzoxathiin SERMsBioorganic & Medicinal Chemistry Letters, 2004
- Ecto-5′-nucleotidase (CD73) regulation by hypoxia-inducible factor-1 mediates permeability changes in intestinal epitheliaJournal of Clinical Investigation, 2002
- Structural basis of substrate specificity in malate dehydrogenases: crystal structure of a ternary complex of porcine cytoplasmic malate dehydrogenase, α-Ketomalonate and TetrahydoNAD 1 1Edited by R. HuberJournal of Molecular Biology, 1999
- Malate-Aspartate Shuttle, Cytoplasmic NADH Redox Potential, and Energetics in Vascular Smooth MuscleJournal of Molecular and Cellular Cardiology, 1998